Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $8.44 Analyst target: $3.00 Upside: -64.45%
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
See the full interactive analysis & chart →Informational only — not investment advice.